published online: 19 January 2017
Kopec B, Fritz IB (1973) Comparison of properties of carnitine palmitoyltransferase I with those of carnitine palmitoyltransferase II, and Preparation of antibodies to carnitine palmitoyltransferases
Insulin Resistance People with significant insulin resistance or type 2 diabetes may see slower initial weight loss but often see faster improvements in blood glucose and metabolic markers
This week, were in Atlanta for ObesityWeek , highlighting WVE-007 and joining the global conversation on transforming obesity care
Semaglutide, marketed under names like Wegovy (for weight loss) and Ozempic (for diabetes), is a newer medication that works differently from Phentermine
Further Perspectives and Conclusions The expanding use of GLP-1 receptor agonists offers a great deal of potential for transforming public health approaches to obesity and type 2 diabetes management